QUOT yields 50.06% · PFE yields 6.13%● Live data
📍 QUOT pulled ahead of the other in Year 1
Combined, QUOT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of QUOT + PFE for your $10,000?
Quotient Technology Inc. operates as a digital media and promotions technology company that offers power integrated digital media and promotions programs for brands and retailers. The company's Quotient Promotions platform offers digital paperless, print promotion, and cash back rebates, including Coupons.com website and mobile applications; brand and retailer websites and mobile applications; and third-party publishing websites and mobile applications. It also provides Quotient Retailer Promotions Platform that uses consumer data and insights to distribute personalized and targeted media and promotions for retailers of grocery, drug, mass merchant, dollar, club, and convenience merchandise; and Quotient Media Platform, which provides targeted advertising solutions that enables brands to reach shoppers before, during, and after their shopping cycles with digital media campaigns. It also provides Quotient Retailer Performance Media Platform that uses retailer's consumer data to drive sales and enhances the shopper experience; Quotient Analytics provides campaign analytics and measured sales results to brands and retailers; Quotient Consumer Properties; and Quotient Retailer Media Services. It serves approximately 900 consumer packed goods, representing approximately 2,500 brands, including various food, beverage, personal care, and household product manufacturers; retail partners representing various classes of trade, such as grocery retailers, drug, mass merchant, dollar, club, and convenience merchandise channels; and consumers visiting its websites, mobile properties, and social channels. The company was formerly known as Coupons.com Incorporated and changed its name to Quotient Technology Inc. in October 2015. Quotient Technology Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
Full QUOT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.